TABLE 3.
Results of screening for sexually transmitted infections (STIs) at baseline visit
|
Total n (%) |
Retained in study n (%) |
Dropouts n (%) |
P‐value a | |
|---|---|---|---|---|
| Any of the STIs listed below | ||||
| Negative | 438 (74.5) | 429 (74.2) | 9 (90.0) | 0.465 |
| Positive | 150 (25.5) | 149 (25.8) | 1 (10.0) | |
| Gonorrhoea | ||||
| Negative | 642 (90.4) | 628 (90.2) | 14 (100) | 0.383 |
| Positive | 68 (9.6) | 68 (9.8) | 0 (0) | |
| Chlamydia | ||||
| Negative | 630 (88.7) | 616 (88.5) | 14 (100) | 0.387 |
| Positive | 80 (11.3) | 80 (11.5) | 0 (0) | |
| Syphilis | ||||
| Negative | 704 (96.3) | 689 (96.4) | 15 (93.8) | 0.456 |
| Positive | 27 (3.7) | 26 (3.6) | 1 (6.2) | |
| Hepatitis C | ||||
| Negative | 606 (100) | 595 (100) | 11 (100) | NA |
| Positive | 0 (0) | 0 (0) | 0 (0) | |
Abbreviation: NA, not applicable.
a
Mann–Whitney U test for continuous variables; Fisher exact test for binary variables.